From: SEMA6A/RhoA/YAP axis mediates tumor-stroma interactions and prevents response to dual BRAF/MEK inhibition in BRAF-mutant melanoma
Patient
Diagnosis
Progression
% of SEMA6A+ cells
Tumor site
1
60%
Back
70%
2
30%
Lung
80%
3
10%
Leg
Occipital fragment